326 related articles for article (PubMed ID: 31672302)
41. Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.
Creemers SG; van Koetsveld PM; van Kemenade FJ; Papathomas TG; Franssen GJ; Dogan F; Eekhoff EM; van der Valk P; de Herder WW; Janssen JA; Feelders RA; Hofland LJ
Endocr Relat Cancer; 2016 Sep; 23(9):727-37. PubMed ID: 27535174
[TBL] [Abstract][Full Text] [Related]
42. The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
Lau SK; Weiss LM
Hum Pathol; 2009 Jun; 40(6):757-68. PubMed ID: 19442788
[TBL] [Abstract][Full Text] [Related]
43. Neonatal Cushing Syndrome: A Rare but Potentially Devastating Disease.
Tatsi C; Stratakis CA
Clin Perinatol; 2018 Mar; 45(1):103-118. PubMed ID: 29406000
[TBL] [Abstract][Full Text] [Related]
44. Cushing's syndrome by left adrenocortical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma: report of a case.
Onoda N; Ishikawa T; Nishio K; Tahara H; Inaba M; Wakasa K; Sumi T; Yamazaki T; Shigematsu K; Hirakawa K
Endocr J; 2009; 56(3):495-502. PubMed ID: 19270420
[TBL] [Abstract][Full Text] [Related]
45. Virilizing adrenocortical adenoma with Cushing's syndrome, thyroid papillary carcinoma and hypergastrinemia in a middle-aged woman.
Fukushima A; Okada Y; Tanikawa T; Kawahara C; Misawa H; Kanda K; Morita E; Sasano H; Tanaka Y
Endocr J; 2003 Apr; 50(2):179-87. PubMed ID: 12803238
[TBL] [Abstract][Full Text] [Related]
46. Serum steroid profiling by mass spectrometry in adrenocortical tumors: diagnostic implications.
Fanelli F; Di Dalmazi G
Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):160-165. PubMed ID: 30893084
[TBL] [Abstract][Full Text] [Related]
47. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.
Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH
Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493
[TBL] [Abstract][Full Text] [Related]
48. Preclinical Cushing syndrome due to an adrenocortical adenoma mimicking late-onset congenital adrenal hyperplasia.
Campos SP; MacGillivray MH
Clin Pediatr (Phila); 1994 Apr; 33(4):246-8. PubMed ID: 8013175
[No Abstract] [Full Text] [Related]
49. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.
Velázquez-Fernández D; Laurell C; Geli J; Höög A; Odeberg J; Kjellman M; Lundeberg J; Hamberger B; Nilsson P; Bäckdahl M
Surgery; 2005 Dec; 138(6):1087-94. PubMed ID: 16360395
[TBL] [Abstract][Full Text] [Related]
50. Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.
Ye J; Qi Y; Wang W; Sun F; Wei Q; Su T; Zhou W; Jiang Y; Yuan W; Cai J; Cui B; Ning G
Endocrine; 2012 Jun; 41(3):479-86. PubMed ID: 22311173
[TBL] [Abstract][Full Text] [Related]
51. IGF2 role in adrenocortical carcinoma biology.
Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
[TBL] [Abstract][Full Text] [Related]
52. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
53. Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.
de Krijger RR; Papathomas TG
Virchows Arch; 2012 Jan; 460(1):9-18. PubMed ID: 22086150
[TBL] [Abstract][Full Text] [Related]
54. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
[TBL] [Abstract][Full Text] [Related]
55. A functioning black adenoma of the adrenal gland.
Ueda Y; Tanaka H; Murakami H; Ninomiya T; Yamashita Y; Ichikawa M; Kondoh T; Chiba T
Intern Med; 1997 Jun; 36(6):398-402. PubMed ID: 9213185
[TBL] [Abstract][Full Text] [Related]
56. Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony.
Stratakis CA
Trends Endocrinol Metab; 2003 Nov; 14(9):404-10. PubMed ID: 14580759
[TBL] [Abstract][Full Text] [Related]
57. A case of adrenocortical adenoma harboring venous thrombus mimicking adrenal malignancy.
Suzuki A; Kamata Y; Taguchi T; Takano K; Yamazaki Y; Sasano H; Shichiri M
Endocr J; 2021 Jul; 68(7):857-863. PubMed ID: 33658437
[TBL] [Abstract][Full Text] [Related]
58. Adreno-cortical tumors: clinico-pathological profile of five cases.
Agarwal G; Mishra SK; Agarwal A; Bhatia V
Indian Pediatr; 1997 Jun; 34(6):521-6. PubMed ID: 9357208
[No Abstract] [Full Text] [Related]
59. From incidentaloma to adrenocortical carcinoma: the surgical management of adrenal tumors.
Shen WT; Sturgeon C; Duh QY
J Surg Oncol; 2005 Mar; 89(3):186-92. PubMed ID: 15719374
[TBL] [Abstract][Full Text] [Related]
60. Proteome analysis of adrenal cortical tumors.
Kim HM; Lee YK; Koo JS
Expert Rev Proteomics; 2016 Aug; 13(8):747-55. PubMed ID: 27385106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
